Why the United States still needs improved dietary supplement regulation and oversight.
It has been 3 years since the American Society for Clinical Pharmacology and Therapeutics (ASCPT) issued a position statement regarding dietary supplement safety and regulation. I was the Chair of the ASCPT task force charged with issuing the statement. At the time, after careful review of available data, the other members and I concluded that dietary supplement legislation in the United States was lacking and that enhanced oversight was essential to increase the safety of these products for the American consumer.
Morrow
J D
JD
Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. jason.morrow@vanderbilt.edu
D026683:Advisory Committees / Q000592:standards* / Q000639:trends*; D000818:Animals; D003254:Consumer Advocacy / Q000592:standards / Q000639:trends; D019587:Dietary Supplements / Q000009:adverse effects / Q000592:standards*; D006801:Humans; D007880:Legislation, Drug / Q000592:standards* / Q000639:trends*; D012926:Social Control, Formal / Q000379:methods; D014481:United States; D014486:United States Food and Drug Administration / Q000592:standards / Q000639:trends